Cargando…
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy
The recent advances in the field of immuno-oncology have dramatically changed the therapeutic strategy against advanced malignancies. Bispecific antibody-based immunotherapies have gained momentum in preclinical and clinical investigations following the regulatory approval of the T cell–redirecting...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for Cancer Research
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306338/ https://www.ncbi.nlm.nih.gov/pubmed/34108185 http://dx.doi.org/10.1158/1078-0432.CCR-20-3770 |